Current Guidelines for the Drug Treatment of Ankylosing Spondylitis
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 56 (2) , 225-240
- https://doi.org/10.2165/00003495-199856020-00006
Abstract
Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease involving spinal and sacroiliac joints. This condition is responsible for back pain, stiffness and discomfort. Several drugs...Keywords
This publication has 97 references indexed in Scilit:
- Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of veterans affairs cooperative studyArthritis & Rheumatism, 1996
- SulfasalazineDrugs, 1995
- Adult-onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitisAmerican Journal of Hematology, 1993
- Ankylosing SpondylitisDrugs, 1992
- D-penicillamine in the therapy of ankylosing spondylitisClinical Rheumatology, 1989
- Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritisClinical Rheumatology, 1986
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984
- A comparative study of Butacote and Naprosyn in ankylosing spondylitis.Annals of the Rheumatic Diseases, 1978
- Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis.Annals of the Rheumatic Diseases, 1978
- Double-blind Cross-over Trial of Flurbiprofen and Phenylbutazone in Ankylosing SpondylitisBMJ, 1974